209 related articles for article (PubMed ID: 26597827)
1. Vitamin D-mediated hypercalcemia in multicentric Castleman's disease.
Tanaka KI; Kanazawa I; Miyake H; Yano S; Amano C; Ishikawa N; Maruyama R; Sugimoto T
J Bone Miner Metab; 2017 Jan; 35(1):122-125. PubMed ID: 26597827
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Treatment Regimens in Management of Severe Hypercalcemia Due to Vitamin D Intoxication in Children.
Demir K; Döneray H; Kara C; Atay Z; Çetinkaya S; Çayır A; Anık A; Eren E; Uçaktürk A; Can Yılmaz G; Törel Ergür A; Kendirci M; Aycan Z; Bereket A; Aydın M; Orbak Z; Özkan B
J Clin Res Pediatr Endocrinol; 2019 May; 11(2):140-148. PubMed ID: 30396880
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D-mediated hypercalcemia in lymphoma: evidence for hormone production by tumor-adjacent macrophages.
Hewison M; Kantorovich V; Liker HR; Van Herle AJ; Cohan P; Zehnder D; Adams JS
J Bone Miner Res; 2003 Mar; 18(3):579-82. PubMed ID: 12619944
[TBL] [Abstract][Full Text] [Related]
4. [Case of mesangial proliferative glomerulonephritis complicated with multicentric Castleman's disease].
Fujiwara H; Mise N; Ishimoto Y; Kotera N; Tanaka M; Tanaka S; Kurita N; Fujii A; Yamaguchi Y; Sugimoto T
Nihon Jinzo Gakkai Shi; 2011; 53(2):189-94. PubMed ID: 21516705
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D-mediated hypercalcemia in slack skin disease: evidence for involvement of extrarenal 25-hydroxyvitamin D 1alpha-hydroxylase.
Karakelides H; Geller JL; Schroeter AL; Chen H; Behn PS; Adams JS; Hewison M; Wermers RA
J Bone Miner Res; 2006 Sep; 21(9):1496-9. PubMed ID: 16939409
[TBL] [Abstract][Full Text] [Related]
6. 1,25-dihydroxyvitamin D and PTHrP mediated malignant hypercalcemia in a seminoma.
Rodríguez-Gutiérrez R; Zapata-Rivera MA; Quintanilla-Flores DL; Camara-Lemarroy CR; Lavalle-Gonzalez FJ; González-González JG; Villarreal-Pérez JZ
BMC Endocr Disord; 2014 Apr; 14():32. PubMed ID: 24721620
[TBL] [Abstract][Full Text] [Related]
7. A patient with severe hypercalcemia in multiple organ dysfunction syndrome: role of elevated circulating 1alpha,25(OH)2 vitamin D levels.
Kazama JJ; Yamamoto T; Oya H; Yamamoto S; Sato Y; Sakurada J; Honda T; Endoh H; Narita I
J Bone Miner Res; 2010 Jun; 25(6):1455-9. PubMed ID: 20200933
[TBL] [Abstract][Full Text] [Related]
8. [Chromosomal abnormalities in Castleman's disease with high levels of serum interleukin-6].
Nakamura H; Nakaseko C; Ishii A; Kogure K; Kawano E; Hashimoto S; Nishimura M; Matsuura Y; Oh H; Yoshida S
Rinsho Ketsueki; 1993 Feb; 34(2):212-7. PubMed ID: 8492420
[TBL] [Abstract][Full Text] [Related]
9. [Multicentric Castleman's disease with multiple hepatic mass lesions mimicking malignant liver tumors].
Ueki T; Nasuno M; Kaiume H; Hiroshima Y; Sumi M; Watanabe M; Inoue D; Masaki Y; Sato Y; Kojima M; Kobayashi H
Rinsho Ketsueki; 2017; 58(6):630-636. PubMed ID: 28679994
[TBL] [Abstract][Full Text] [Related]
10. Hypercalcemia Associated with the Ectopic Expression of 25-hydroxyvitamin D3-1α-hydroxylase in Diffuse Large B-cell Lymphoma.
Ogawa M; Morikawa M; Kobatake M; Murakami T; Yamamoto Y; Watanabe R; Yamada K; Nishiyama K; Yasutomo Y; Hara K
Intern Med; 2022; 61(16):2489-2495. PubMed ID: 35965075
[TBL] [Abstract][Full Text] [Related]
11. The other side of vitamin D therapy:
a case series of acute kidney injury due to malpractice-related vitamin D intoxication
.
Wani M; Wani I; Banday K; Ashraf M
Clin Nephrol; 2016 Nov; 86 (2016)(11):236-241. PubMed ID: 27719737
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.
Tebben PJ; Singh RJ; Kumar R
Endocr Rev; 2016 Oct; 37(5):521-547. PubMed ID: 27588937
[TBL] [Abstract][Full Text] [Related]
13. Hypercalcemia, nephrolithiasis, and hypervitaminosis D precipitated by supplementation in a susceptible individual.
Haridas K; Holick MF; Burmeister LA
Nutrition; 2020 Jun; 74():110754. PubMed ID: 32222584
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous multicentric Castleman's disease mimicking IgG4-related disease.
Takeuchi M; Sato Y; Takata K; Kobayashi K; Ohno K; Iwaki N; Orita Y; Yoshino T
Pathol Res Pract; 2012 Dec; 208(12):746-9. PubMed ID: 23102767
[TBL] [Abstract][Full Text] [Related]
15. Abnormal calcium metabolism caused by increased circulating 1,25-dihydroxyvitamin D in a patient with rheumatoid arthritis.
Gates S; Shary J; Turner RT; Wallach S; Bell NH
J Bone Miner Res; 1986 Apr; 1(2):221-6. PubMed ID: 3503540
[TBL] [Abstract][Full Text] [Related]
16. Hypercalcemia as a result of sarcoidosis with normal serum concentrations of vitamin D.
Falk S; Kratzsch J; Paschke R; Koch CA
Med Sci Monit; 2007 Nov; 13(11):CS133-136. PubMed ID: 17968303
[TBL] [Abstract][Full Text] [Related]
17. CYP24A1 Mutations in a Cohort of Hypercalcemic Patients: Evidence for a Recessive Trait.
Molin A; Baudoin R; Kaufmann M; Souberbielle JC; Ryckewaert A; Vantyghem MC; Eckart P; Bacchetta J; Deschenes G; Kesler-Roussey G; Coudray N; Richard N; Wraich M; Bonafiglia Q; Tiulpakov A; Jones G; Kottler ML
J Clin Endocrinol Metab; 2015 Oct; 100(10):E1343-52. PubMed ID: 26214117
[TBL] [Abstract][Full Text] [Related]
18. Systemic juvenile idiopathic arthritis mimics multicentric Castleman's disease.
Osone S; Morimoto A; Tsutsui J; Kano G; Todo S; Sugimoto T
Clin Rheumatol; 2003 Dec; 22(6):484-6. PubMed ID: 14677035
[TBL] [Abstract][Full Text] [Related]
19. Sarcoidosis initially manifesting as symptomatic hypercalcemia with the absence of organic involvement.
Motoyama K; Inaba M; Emoto M; Morii H; Nishizawa Y
Intern Med; 2002 Jun; 41(6):449-52. PubMed ID: 12135177
[TBL] [Abstract][Full Text] [Related]
20. Hypercalcemia due to hypervitaminosis D: report of seven patients.
Joshi R
J Trop Pediatr; 2009 Dec; 55(6):396-8. PubMed ID: 19339514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
